β-talasemia major
Wątpliwości i zagrożenia związane z transfuzją
Seropositivity of hepatitis C, hepatitis B and HIV in chronically transfused β-thalassaemia major patients. (opens new window)
Źródło: J Coll Physicians Surg Pak 2012;22(9):610-1.
Clinical outcome of frequent exposure to Torque Teno virus (TTV) through blood transfusion in thalassemia patients with or without hepatitis C virus (HCV) infection. (opens new window)
Źródło: J Med Virol 2008;80(2):365-71.
Prevalence of alloimmunisation in patients with beta thalassaemia major. (opens new window)
Źródło: Blood Transfus 2012;10(3):396-7.
Marseillevirus prevalence in multitransfused patients suggests blood transmission. (opens new window)
Źródło: J Clin Virol 2013;58(4):722-5.
Thalassemia Major in Adults: Short Stature, Hyperpigmentation, Inadequate Chelation, and Transfusion-Transmitted Infections are Key Features. (opens new window)
Źródło: N Am J Med Sci 2012;4(3):141-4.
